Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation (Q48820280)

15 February 2018

title

Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation (English)

1 reference

15 February 2018

0 references

0 references

1 reference

Xiaona Xing

1

1 reference

15 February 2018

Sha Sha

2

1 reference

15 February 2018

Yu Li

3

1 reference

15 February 2018

Lixia Zong

4

1 reference

15 February 2018

Tongzi Jiang

5

1 reference

15 February 2018

Yunpeng Cao

6

1 reference

15 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22029939

15 December 2024

publication date

24 October 2011

1 reference

15 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0022510X11006022?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

https://api.elsevier.com/content/article/PII:S0022510X11006022?httpAccept=text/plain

15 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Journal of the Neurological Sciences

15 December 2024

published in

1 reference

15 February 2018

volume

313

1 reference

15 February 2018

issue

1-2

1 reference

15 February 2018

page(s)

17-21

1 reference

15 February 2018

Alzheimer's disease: the amyloid cascade hypothesis

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

15 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

15 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

15 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

15 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

15 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

15 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

15 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

15 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.

15 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

15 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch

15 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice.

15 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response

15 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease

15 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

15 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

15 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

N-terminal EFRH sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies

15 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain

15 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis

15 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF.

15 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets

15 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene

15 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Reduced Pathology and Improved Behavioral Performance in Alzheimer's Disease Mice Vaccinated With HSV Amplicons Expressing Amyloid-β and Interleukin-4

15 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

15 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention

15 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

In vivo DNA electrotransfer into muscle

15 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Electroporation-based DNA immunisation: translation to the clinic

15 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety

15 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.

15 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

15 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JNS.2011.09.040

15 December 2024

Identifiers

1 reference

15 February 2018

1 reference

15 February 2018